CD36 and chronic kidney disease: This is supported by evidence showing triglyceride accumulation in renal cells induces lipotoxicity and inflammation via CD36-mediated lipid uptake, accelerating CKD progression, while interventions modulating triglyceride metabolism can attenuate renal injury [46,47].